Products
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceHiro for Analytics
Synapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
2026 R&D Benchmark Report
Glossary
Free tools
NEWWebinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
No credit card required
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Optical neural networks are moving from lab to chip. Explore the 2026 technology landscape: key architectures, throughput records, geographic leaders, and emerging IP signals.
Article | Report Gate-first vs gate-last high-k metal gate integration: thermal budget trade-offs, work function engineering, EOT scaling, and hybrid CMOS schemes explained.
Article | Report IPMC actuator technology landscape 2026: fabrication breakthroughs, alternative membranes, air-stable operation, and emerging patent white spaces across soft robotics and biomedical devices.
Article | Report Why wafer-scale ALD uniformity is the binding constraint in 3D NAND word line fill — covering step coverage, Vth spread, wafer bow, metrology gaps, and void formation.
Article | Report CRH receptor, ACTH, and adrenal steroidogenesis inhibitor approaches in the Cushing's disease drug pipeline — patent signals, clinical data, and emerging targets.
Article | Report Why achieving wafer-scale ALD uniformity in 3D NAND word line fill is the binding yield constraint at 100–176 layers — engineering challenges and patent-backed solutions.
Article | Report SQUID technology landscape 2026: patent trends, key assignees (CSIRO, IBM, Huawei), emerging architectures, and strategic IP implications for quantum computing and space astronomy.
Article | Report Beyond lumasiran: how RNAi, CRISPR-Cas9, small-molecule LDH inhibitors, and microbiome therapy are reshaping the primary hyperoxaluria treatment pipeline.
Article | Report How gallium oxide (Ga2O3) surpasses SiC and GaN with a BFOM of 3,300 and 4.9 eV bandgap — and what engineering barriers remain before it reshapes power electronics.
Article | Report Piezoelectric MEMS microphone patent landscape 2026: key assignees, technology clusters, application domains, and emerging directions from 30+ patents and papers.
Article | Report Costimulation blockade, IL-2 muteins, and belatacept-next approaches: a mechanistic review of the solid organ transplant rejection drug pipeline.
Article | Report How Ga2O3's 4.9 eV bandgap and BFOM of 3,300 position it beyond SiC and GaN for next-generation power switching devices. Research, devices, and engineering challenges.
Article | Report Map the 2026 piezoelectric MEMS microphone landscape: key patents, assignees, materials, and emerging directions from cantilever designs to CMOS integration.
Article | Report TDR vs FDR for high-voltage cable fault location: operating principles, resolution limits, soft fault detection, and hybrid TFDR methods compared across 50+ patents.
Article | Report Live biotherapeutics, postbiotics, and engineered strain approaches are reshaping the gut microbiome therapeutics pipeline beyond FMT. Explore the science.